Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, Italy.
Department of Veterinary Sciences, University of Messina, Messina, Italy.
Nat Prod Res. 2022 May;36(10):2672-2691. doi: 10.1080/14786419.2021.1914032. Epub 2021 May 5.
Viral diseases have always played an important role in public and individual health. Since December 2019, the world is facing a pandemic of SARS-CoV-2, a coronavirus that results in a syndrome known as COVID-19. Several studies were conducted to implement antiviral drug therapy, until the arrival of SARS-CoV-2 vaccines. Numerous scientific investigations have considered some nutraceuticals as an additional treatment of COVID-19 patients to improve their clinical picture. In this review, we would like to emphasize the studies conducted to date about this issue and try to understand whether the use of nutraceuticals as a supplementary therapy to COVID-19 may be a valid and viable avenue. Based on the results obtained so far, quercetin, astaxanthin, luteolin, glycyrrhizin, lactoferrin, hesperidin and curcumin have shown encouraging data suggesting their use to prevent and counteract the symptoms of this pandemic infection.
病毒性疾病一直对公众和个人的健康起着重要作用。自 2019 年 12 月以来，世界正面临着由冠状病毒引起的 SARS-CoV-2 大流行，这种冠状病毒导致了一种称为 COVID-19 的综合征。为了实施抗病毒药物治疗，直到 SARS-CoV-2 疫苗问世。许多科学研究已经将一些营养保健品作为 COVID-19 患者的附加治疗方法，以改善他们的临床症状。在这篇综述中，我们想强调迄今为止关于这个问题的研究，并试图了解营养保健品作为 COVID-19 辅助治疗的使用是否可能是一个有效和可行的途径。基于迄今为止获得的结果，槲皮素、虾青素、木犀草素、甘草酸、乳铁蛋白、橙皮苷和姜黄素显示出令人鼓舞的数据，表明它们可用于预防和对抗这种大流行感染的症状。
